Valuation: EMVision Medical Devices Ltd

Market Cap 144M 99.79M 87.69M 81.85M 75.12M 141M 9.56B 971M 380M 4.73B 375M 367M 16.35B P/E 2026 *
-15.8x
P/E 2027 * -13.7x
Enterprise Value 144M 99.79M 87.69M 81.85M 75.12M 141M 9.56B 971M 380M 4.73B 375M 367M 16.35B EV / Sales 2026 *
26.2x
EV / Sales 2027 * 28.8x
Free-Float
66.78%
Yield 2026 *
-
Yield 2027 * -
1 week-5.49%
Current month+2.31%
1 month+2.31%
3 months-11.93%
6 months-12.43%
Current year-12.92%
1 week 1.52
Extreme 1.525
1.64
1 month 1.47
Extreme 1.47
1.76
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.28
Extreme 1.275
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Director/Board Member 80 29/09/2020
Director/Board Member - 05/06/2025
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap.
4/23/26 A Buy

Director

10,000 0.0108%
1/2/26 A Expiration

Chairman

300,000 0.3228%
11/18/25 A Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-5.49%-13.65%+25.00% 101M
+1.40%+8.87%+18.87%+4.47% 214B
-3.51%+10.14%-4.62%-22.65% 140B
-1.72%+3.87%-28.78%+9.09% 128B
-2.26%+7.89%-56.46%-10.59% 68.46B
+2.18%+1.46%+6.38%+4.30% 48.18B
+4.51%+8.59%-22.65%-28.93% 45.56B
-0.03%+5.16%+17.11%+15.25% 39.69B
+0.66%+2.47%+25.33%+37.57% 37.69B
+2.62%+10.67%-23.12%-3.98% 30.14B
Average +0.08%+4.91%-8.16%+2.95% 75.18B
Weighted average by Cap. -0.63%+6.96%-5.24%-1.31%

Financials

2026 *2027 *
Net sales 5.5M 3.81M 3.35M 3.12M 2.87M 5.37M 365M 37.05M 14.49M 181M 14.3M 13.99M 624M 5M 3.46M 3.04M 2.84M 2.61M 4.88M 332M 33.68M 13.17M 164M 13M 12.72M 567M
Net income -9.1M -6.3M -5.54M -5.17M -4.74M -8.88M -604M -61.3M -23.97M -299M -23.66M -23.15M -1.03B -12M -8.31M -7.3M -6.82M -6.26M -11.71M -796M -80.84M -31.61M -394M -31.21M -30.53M -1.36B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
29/07/26 A$1.550 0.00% 11,784
28/07/26 A$1.550 -3.13% 11,758
27/07/26 A$1.600 +3.90% 21,027
24/07/26 A$1.540 -5.23% 41,760
23/07/26 A$1.625 -0.61% 1,007
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.550AUD
Average target price
3.150AUD
Spread / Average Target
+103.23%

Annual profits - Rate of surprise